carbenoxolone sodium has been researched along with Cancer of Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoyav, B; Benny, O; Ella, E; Friedman, N; Karsch-Bluman, A; Schwob, O; Shoval, H; Wald, O | 1 |
1 other study(ies) available for carbenoxolone sodium and Cancer of Lung
| Article | Year |
|---|---|
High mobility group box 1 antagonist limits metastatic seeding in the lungs via reduction of cell-cell adhesion.
Topics: Animals; Carbenoxolone; Cell Adhesion; Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; Intercellular Adhesion Molecule-1; Lung Neoplasms; Mice; RAW 264.7 Cells; Receptor for Advanced Glycation End Products; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2017 |